Results 221 to 230 of about 104,742 (284)
Some of the next articles are maybe not open access.
Advanced Healthcare Materials, 2021
Malignant pleural effusion (MPE) remains a treatment bottleneck in advanced lung cancer, due to its complicated microenvironments and “cold” immunity. Therefore, the search for therapeutic drugs to transform MPE to functionally “hot” one could advance ...
Zhenhuan Song +5 more
semanticscholar +1 more source
Malignant pleural effusion (MPE) remains a treatment bottleneck in advanced lung cancer, due to its complicated microenvironments and “cold” immunity. Therefore, the search for therapeutic drugs to transform MPE to functionally “hot” one could advance ...
Zhenhuan Song +5 more
semanticscholar +1 more source
Malignant Pleural Effusions [PDF]
Seminars in Respiratory and Critical Care Medicine, 1985 Various diseases of the gastrointestinal tract at times are accompanied by an exudative pleural effusion. The exudative pleural effusions resulting from esophageal perforation, pancreatic disease, subphrenic abscess, intrahepatic abscess, splenic abscess, abdominal operations, and diaphragmatic hernia are discussed in this article.
openaire +4 more sources
Cancer Treatment Reviews, 1978
Recurrent malignant pleural effusion is a relatively common problem that often occurs many months before the terminal stages of a patient's malignant disease. Despite careful evaluation, it is often impossible to identify the exact physiologic cause of an effusion and difficult to identify a pragmatic course of therapy.
Michael A. Friedman, Evan Slater
openaire +3 more sources
Recurrent malignant pleural effusion is a relatively common problem that often occurs many months before the terminal stages of a patient's malignant disease. Despite careful evaluation, it is often impossible to identify the exact physiologic cause of an effusion and difficult to identify a pragmatic course of therapy.
Michael A. Friedman, Evan Slater
openaire +3 more sources
Science Translational Medicine, 2019
This study investigated the application of a therapeutic tumor cell–derived microparticle-based nanodelivery platform in malignant pleural effusion. Insider attack on tumors A major factor that limits the effectiveness of cancer therapy is the ability to
Mengfei Guo +21 more
semanticscholar +1 more source
This study investigated the application of a therapeutic tumor cell–derived microparticle-based nanodelivery platform in malignant pleural effusion. Insider attack on tumors A major factor that limits the effectiveness of cancer therapy is the ability to
Mengfei Guo +21 more
semanticscholar +1 more source
Pleurodesis for malignant pleural effusions
Cochrane Database of Systematic Reviews, 2000Approximately half of all patients with metastatic cancer develop a malignant pleural effusion which is likely to lead to a significant reduction in quality of life secondary to symptoms such as dyspnoea and cough. The aim of pleurodesis in these patients is to prevent re-accumulation of the effusion and thereby of symptoms, and avoid the need for ...
Roshan Agarwal, Paul Shaw
openaire +4 more sources
Clinics in Chest Medicine, 2013
Malignant pleural effusions are a cause of significant symptoms and distress in patients with end-stage malignancies and portend a poor prognosis. Management is aimed at symptom relief, with minimally invasive interventions and minimal requirement for hospital length of stay.
Ali I. Musani, Justin Thomas
openaire +3 more sources
Malignant pleural effusions are a cause of significant symptoms and distress in patients with end-stage malignancies and portend a poor prognosis. Management is aimed at symptom relief, with minimally invasive interventions and minimal requirement for hospital length of stay.
Ali I. Musani, Justin Thomas
openaire +3 more sources
Current Treatment Options in Oncology, 2001
Malignant pleural effusions contribute to considerable morbidity in cancer patients and generally portend an overall poor prognosis. Treatment of malignant pleural effusions is palliative; therefore, quality of life issues, as well as the risks and benefits of the therapeutic options, become more critical.
openaire +3 more sources
Malignant pleural effusions contribute to considerable morbidity in cancer patients and generally portend an overall poor prognosis. Treatment of malignant pleural effusions is palliative; therefore, quality of life issues, as well as the risks and benefits of the therapeutic options, become more critical.
openaire +3 more sources
Management of Malignant Pleural Effusions
Drugs, 1998Malignant pleural effusions (MPEs) represent a common complication of advanced malignancies. However, adequate palliation of this highly symptomatic accompaniment to cancer can be achieved in most patients by adopting the appropriate therapy. Several options are available for the treatment of MPE.
Grossi F +4 more
openaire +3 more sources